USP39 and renal cell carcinoma: For patients with low TNM stage, the predictive ability of USP39 expression was stronger than that of TNM stage, and the combination of the two indexes could significantly improve the ability of predicting survival of RCC patients (P < 0.001) (Fig. 2C).